Moore Capital Management’s SomaLogic Warrant SLGCW Stock Holding History
Bought
Maintained
Sold
Other funds holding SLGCW
Moore Capital Management's SLGCW Position: Q1 2022 in Review
Moore Capital Management sold out of SomaLogic Warrant (SLGCW) in Q1 2022, closing a stake of 50,000 shares — an estimated $168K sold.
Moore Capital Management first reported a position in SLGCW in Q2 2021 and held it in 3 quarters. The position peaked at $369K in Q2 2021. 28 funds tracked by Wall St. Rank hold SLGCW as of Q1 2022.
- Moore Capital Management reported no remaining SomaLogic Warrant position as of Q1 2022 after selling out during the quarter.
- Moore Capital Management sold 50,000 SomaLogic Warrant shares in Q1 2022, an estimated $168K.
- Moore Capital Management first reported a position in SomaLogic Warrant in Q2 2021 and held it in 3 quarters.
- Moore Capital Management's SomaLogic Warrant position peaked at $369K in Q2 2021.
- 28 funds tracked by Wall St. Rank held SomaLogic Warrant as of Q1 2022.
Based on Moore Capital Management's 13F filing for Q1 2022, filed 16 May 2022.